Flores-Martínez S E, Dean M, Saiki R K, Gallegos-Arreola M P, Morán-Moguel M C, Sánchez-Corona J
División de Medicina Molecular, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, México.
Hum Mutat. 1998;12(3):217-8.
We have analyzed 45 unrelated Northwestern Mexican patients with Cystic Fibrosis for 10 known CF mutations (DF508, G542X, G551D. R553X, W1282X, NI303K, R334W, R347H, S549R, and R1162X). Screening was performed on exons 7, 10, 11, 19, 20 and 21 using standard methods such as polymerase chain reactions, reverse dot blot hybridization (non-radioactive), and restriction enzyme digestion. The analysis for these ten mutations permitted the identification of only two mutations in 37.7% of CF chromosomes in this sample. The major mutation, delta F508, accounts for 34.4% of CF chromosomes. Of the 45 CF patients 9 (20.0%) were homozygous delta F508 deletion, 11 (24.4%) were heterozygous for the delta F508 mutation and an unknown mutation. One additional mutation G542X was also found in 3 chromosomes in our population (3.3%). Two patients were documented to be a compound heterozygote for DF508/G542X, and other one heterozygous for G542X and an unknown mutation. Therefore 62.2% of chromosomes remain uncharacterized.
我们分析了45名来自墨西哥西北部、无亲缘关系的囊性纤维化患者,检测了10种已知的囊性纤维化基因突变(DF508、G542X、G551D、R553X、W1282X、NI303K、R334W、R347H、S549R和R1162X)。采用聚合酶链反应、反向斑点杂交(非放射性)和限制性酶切等标准方法,对第7、10、11、19、20和21外显子进行筛查。对这10种突变的分析显示,在该样本中,仅在37.7%的囊性纤维化染色体上鉴定出两种突变。主要突变Delta F508占囊性纤维化染色体的34.4%。在45名囊性纤维化患者中,9名(20.0%)为Delta F508缺失纯合子,11名(24.4%)为Delta F508突变杂合子且携带一种未知突变。在我们的研究人群中,还在3条染色体上发现了另一种突变G542X(3.3%)。两名患者被证实为DF508/G542X复合杂合子,另一名患者为G542X杂合子且携带一种未知突变。因此,62.2%的染色体仍未明确。